The global apheresis equipment market size is calculated at USD 3.51 billion in 2025 and is forecasted to reach around USD 7.77 billion by 2034, accelerating at a CAGR of 9,.24% from 2025 to 2034. The North America market size surpassed USD 1.12 billion in 2024 and is expanding at a CAGR of 9.44% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Apheresis Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Apheresis Equipment Market Revenue and Volume Forecast, by Product
8.1.1. Disposable Apheresis Kits
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Devices
8.1.2.1. Market Revenue and Volume Forecast
9.1. Apheresis Equipment Market Revenue and Volume Forecast, by Procedure
9.1.1. Plasmapheresis
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Photopheresis
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Leukapheresis
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Plateletpheresis
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. LDL Apheresis
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Erythrocytapheresis
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast
10.1. Apheresis Equipment Market Revenue and Volume Forecast, by Technology
10.1.1. Membrane Filtration
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Centrifugation
10.1.2.1. Market Revenue and Volume Forecast
11.1. Apheresis Equipment Market Revenue and Volume Forecast, by Application
11.1.1. Renal Diseases
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Hematology
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Neurology
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product
12.1.2. Market Revenue and Volume Forecast, by Procedure
12.1.3. Market Revenue and Volume Forecast, by Technology
12.1.4. Market Revenue and Volume Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product
12.1.5.2. Market Revenue and Volume Forecast, by Procedure
12.1.5.3. Market Revenue and Volume Forecast, by Technology
12.1.5.4. Market Revenue and Volume Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product
12.1.6.2. Market Revenue and Volume Forecast, by Procedure
12.1.6.3. Market Revenue and Volume Forecast, by Technology
12.1.6.4. Market Revenue and Volume Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product
12.2.2. Market Revenue and Volume Forecast, by Procedure
12.2.3. Market Revenue and Volume Forecast, by Technology
12.2.4. Market Revenue and Volume Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product
12.2.5.2. Market Revenue and Volume Forecast, by Procedure
12.2.5.3. Market Revenue and Volume Forecast, by Technology
12.2.5.4. Market Revenue and Volume Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product
12.2.6.2. Market Revenue and Volume Forecast, by Procedure
12.2.6.3. Market Revenue and Volume Forecast, by Technology
12.2.6.4. Market Revenue and Volume Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product
12.2.7.2. Market Revenue and Volume Forecast, by Procedure
12.2.7.3. Market Revenue and Volume Forecast, by Technology
12.2.7.4. Market Revenue and Volume Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product
12.2.8.2. Market Revenue and Volume Forecast, by Procedure
12.2.8.3. Market Revenue and Volume Forecast, by Technology
12.2.8.4. Market Revenue and Volume Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product
12.3.2. Market Revenue and Volume Forecast, by Procedure
12.3.3. Market Revenue and Volume Forecast, by Technology
12.3.4. Market Revenue and Volume Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product
12.3.5.2. Market Revenue and Volume Forecast, by Procedure
12.3.5.3. Market Revenue and Volume Forecast, by Technology
12.3.5.4. Market Revenue and Volume Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product
12.3.6.2. Market Revenue and Volume Forecast, by Procedure
12.3.6.3. Market Revenue and Volume Forecast, by Technology
12.3.6.4. Market Revenue and Volume Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product
12.3.7.2. Market Revenue and Volume Forecast, by Procedure
12.3.7.3. Market Revenue and Volume Forecast, by Technology
12.3.7.4. Market Revenue and Volume Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product
12.3.8.2. Market Revenue and Volume Forecast, by Procedure
12.3.8.3. Market Revenue and Volume Forecast, by Technology
12.3.8.4. Market Revenue and Volume Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product
12.4.2. Market Revenue and Volume Forecast, by Procedure
12.4.3. Market Revenue and Volume Forecast, by Technology
12.4.4. Market Revenue and Volume Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product
12.4.5.2. Market Revenue and Volume Forecast, by Procedure
12.4.5.3. Market Revenue and Volume Forecast, by Technology
12.4.5.4. Market Revenue and Volume Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product
12.4.6.2. Market Revenue and Volume Forecast, by Procedure
12.4.6.3. Market Revenue and Volume Forecast, by Technology
12.4.6.4. Market Revenue and Volume Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product
12.4.7.2. Market Revenue and Volume Forecast, by Procedure
12.4.7.3. Market Revenue and Volume Forecast, by Technology
12.4.7.4. Market Revenue and Volume Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product
12.4.8.2. Market Revenue and Volume Forecast, by Procedure
12.4.8.3. Market Revenue and Volume Forecast, by Technology
12.4.8.4. Market Revenue and Volume Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product
12.5.2. Market Revenue and Volume Forecast, by Procedure
12.5.3. Market Revenue and Volume Forecast, by Technology
12.5.4. Market Revenue and Volume Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product
12.5.5.2. Market Revenue and Volume Forecast, by Procedure
12.5.5.3. Market Revenue and Volume Forecast, by Technology
12.5.5.4. Market Revenue and Volume Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product
12.5.6.2. Market Revenue and Volume Forecast, by Procedure
12.5.6.3. Market Revenue and Volume Forecast, by Technology
12.5.6.4. Market Revenue and Volume Forecast, by Application
13.1. Asahi Kasei Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerProductance
13.1.4. Recent Initiatives
13.2. B. Braun SE
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerProductance
13.2.4. Recent Initiatives
13.3. Cerus Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProductance
13.3.4. Recent Initiatives
13.4. Fresenius SE & Co. KGaA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProductance
13.4.4. Recent Initiatives
13.5. Haemonetics Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProductance
13.5.4. Recent Initiatives
13.6. Haier Biomedical
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProductance
13.6.4. Recent Initiatives
13.7. Medica SPA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProductance
13.7.4. Recent Initiatives
13.8. Miltenyi Biotec
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProductance
13.8.4. Recent Initiatives
13.9. NIKKISO Medical Europe GmbH
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProductance
13.9.4. Recent Initiatives
13.10. NxStage Medical, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProductance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client